On 2023-11-14, Bone Biologics Corp. (BBLG) announced earnings per share of $-4.88 for the fiscal quarter ending 2023-09-30, beating the average analyst estimate of $-24.32.
The next expected annoucement date for quarterly earnings is 2024-05-20, with an average estimated earnings per share of $-7.60 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-11-14 | 2023-09-30 | $-24.32 | $-4.88 |
| 2023-08-14 | 2023-06-30 | $-12.00 | $-13.52 |
| 2023-05-15 | 2023-03-31 | $-360.36 | $-55.26 |
| 2023-03-30 | 2022-12-31 | -- | $24.02 |
| 2022-11-14 | 2022-09-30 | $-60.06 | $-28.83 |
| 2022-08-11 | 2022-06-30 | $-28.83 | $-12.01 |
| 2022-05-13 | 2022-03-31 | $-48.05 | $-16.82 |
| 2021-11-15 | 2021-09-30 | -- | $-40.84 |
| 2021-08-16 | 2021-06-30 | -- | $-16.82 |
| 2021-05-21 | 2021-03-31 | -- | $-14.41 |